Schonfeld Strategic Advisors LLC Heron Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $125,176 - $259,810	-55,634 Reduced 58.98%	38,700 $96,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $250,928 - $506,573	94,334 New	94,334 $397,000
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $133,807 - $287,266	-28,900 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $181,195 - $273,420	-21,700 Reduced 42.89%	28,900 $264,000
Q3 2021 Nov 16, 2021	BUY	$10.13 - $15.0 $85,092 - $126,000	8,400 Added 19.91%	50,600 $541,000
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $559,994 - $779,856	42,200 New	42,200 $655,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.